CVRS News and Press, Corindus Vascular Robotics Inc. (DE) From 07/17/19

Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it received approval from the Australian Therapeutic Goods ...

Brazil’s Albert Einstein Jewish Hospital continues reputation as pioneer in medical robotics Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announce...

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...

Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that the Company will join the broad-market Russell 3000 ® Index at the conclusion of the 2019 Russell ...

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...

The stock price of Corindus Vascular Robotics, Inc. ( CVRS ) has been steadily climbing up during the past year. It has gone up by 87% for the past year, reaching $3.00 as of June 2019. This is a rare success considering the US equity market has been declining since the latter half of 2018, du...

SIMPLIFYING RECENT INNOVATON ANNOUNCEMENTS AT HRS IN TERMS OF REVENUE AND PROFITABLITY; STRONG POTENTIAL OUTLOOK WITH OVER $60 MILLION IN SALES AND LARGE PROFITS FROM JUST EXISTING CUSTOMER BASE Stereotaxis is a global pioneer and leader of robotics for endovascular surgery with a fantasti...

Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today its CorPat...

Company will highlight CorPath GRX capabilities in complex vascular procedures Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will show...

Company to feature latest milestones and technology advancements in vascular robotics at SCAI 2019 Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, will sponsor ...